---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-001482"
form_type: "8-K"
ticker: "QNCX"
cik: "0001662774"
company_name: "Quince Therapeutics, Inc."
filed_at: "2024-01-03T23:59:59+00:00"
generated_at: "2026-06-07T04:43:02.825254+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Quince Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Nasdaq notified Quince on Dec 4, 2023 of non-compliance due to bid price below $1.00 for 30 consecutive days.
- On Dec 29, 2023, Nasdaq confirmed compliance after closing bid price ≥ $1.00 for 13 consecutive business days.
- The matter is closed; Quince remains listed on the Nasdaq Global Select Market.

## SEC filing metadata
- accession: 0001193125-24-001482
- form_type: 8-K
- ticker: QNCX
- cik: 0001662774
- company_name: Quince Therapeutics, Inc.
- filed_at: 2024-01-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662774/000119312524001482/0001193125-24-001482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662774/000119312524001482/d641060d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-001482
- JSON: https://secwatch.observer/filing/0001193125-24-001482.json
- Plain text: https://secwatch.observer/filing/0001193125-24-001482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.